{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T04:11:04Z","timestamp":1773202264477,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1016\/s0306-4530(02)00130-0","type":"journal-article","created":{"date-parts":[[2003,3,25]],"date-time":"2003-03-25T19:21:05Z","timestamp":1048620065000},"page":"109-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"special_numbering":"S2","title":["What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning?"],"prefix":"10.1016","volume":"28","author":[{"given":"H.","family":"Knegtering","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.E.G.M.","family":"van der Moolen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Castelein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kluiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.J.","family":"van den Bosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0306-4530(02)00130-0_BIB1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.4088\/JCP.v62n07a07","article-title":"Comparison of sexual dysfunction in male schizophrenic patients maintained on treatment with classical antipsychotics versus clozapine","volume":"62","author":"Aizenberg","year":"2001","journal-title":"J. Clin. Psychiat."},{"key":"10.1016\/S0306-4530(02)00130-0_BIB2","first-page":"137","article-title":"Sexual dysfunction in male schizophrenic patients","volume":"56","author":"Aizenberg","year":"1995","journal-title":"J. Clin. Psychiat."},{"key":"10.1016\/S0306-4530(02)00130-0_BIB3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/13651509709069205","article-title":"Effects of antidepressant drugs on sexual function","volume":"1","author":"Baldwin","year":"1997","journal-title":"Int. J. Psychiat. Clin. Pract."},{"key":"10.1016\/S0306-4530(02)00130-0_BIB4","series-title":"Sexual Pharmacology","first-page":"176","article-title":"Psychiatric drugs and sexuality","author":"Barnes","year":"1993"},{"key":"10.1016\/S0306-4530(02)00130-0_BIB5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0006-3223(94)91164-9","article-title":"A pilot study of a structured interview addressing sexual functioning in men with schizophrenia","volume":"35","author":"Burke","year":"1994","journal-title":"Biol. Psychiat."},{"key":"10.1016\/S0306-4530(02)00130-0_BIB6","first-page":"48","article-title":"Prolactin and testosterone: their role in male sexual function","volume":"19","author":"Caranai","year":"1996","journal-title":"J. Androl."},{"key":"10.1016\/S0306-4530(02)00130-0_BIB7","series-title":"Sexual Pharmacology","article-title":"Drugs that effect sexual functioning","author":"Crenshaw","year":"1996"},{"key":"10.1016\/S0306-4530(02)00130-0_BIB8","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/S0920-9964(98)00159-5","article-title":"Neuroleptic-induced hyperprolactinemia","volume":"35","author":"Dickson","year":"1999","journal-title":"Schizophr. Res."},{"key":"10.1016\/S0306-4530(02)00130-0_BIB9","series-title":"Principles of Neuropsychopharmacology","first-page":"319","article-title":"The role of dopamine in motivational processes","author":"Feldman","year":"1997"},{"key":"10.1016\/S0306-4530(02)00130-0_BIB10","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1017\/S0033291700036539","article-title":"Subjective utility ratings of neuroleptics in treating schizophrenia","volume":"35","author":"Finn","year":"1990","journal-title":"Psychol. Med."},{"key":"10.1016\/S0306-4530(02)00130-0_BIB11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00005053-198208000-00004","article-title":"Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients","volume":"170","author":"Ghadirian","year":"1982","journal-title":"J. Nerv. Ment. Disord."},{"key":"10.1016\/S0306-4530(02)00130-0_BIB12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0889-8529(18)30442-0","article-title":"Prolactin and neuroleptic drugs","volume":"17","author":"Green","year":"1988","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/S0306-4530(02)00130-0_BIB13","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/schbul\/22.3.447","article-title":"Accelerated osteoporosis in psychiatric patients: possible pathophysiological processes","volume":"22","author":"Halbreich","year":"1996","journal-title":"Schizophr. Bull."},{"issue":"5","key":"10.1016\/S0306-4530(02)00130-0_BIB14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00006842-199509000-00011","article-title":"Decreased bone mineral density in medicated psychiatric patients","volume":"57","author":"Halbreich","year":"1995","journal-title":"Psychosom. Med."},{"key":"10.1016\/S0306-4530(02)00130-0_BIB15","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1176\/ajp.156.4.631","article-title":"Sexual disturbances during clozapine and haloperidol treatment for schizophrenia","volume":"4","author":"Hummer","year":"1999","journal-title":"Am. J. Psychiat."},{"issue":"3","key":"10.1016\/S0306-4530(02)00130-0_BIB16","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1176\/appi.ajp.158.3.360","article-title":"Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics?: a new hypothesis","volume":"158","author":"Kapur","year":"2001","journal-title":"Am. J. Psychiat."},{"issue":"6","key":"10.1016\/S0306-4530(02)00130-0_BIB17","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archpsyc.57.6.553","article-title":"A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy","volume":"57","author":"Kapur","year":"2000","journal-title":"Arch. Gen. Psychiat."},{"issue":"2","key":"10.1016\/S0306-4530(02)00130-0_BIB18","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1176\/ajp.156.2.286","article-title":"Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia","volume":"156","author":"Kapur","year":"1999","journal-title":"Am. J. Psychiat."},{"issue":"7","key":"10.1016\/S0306-4530(02)00130-0_BIB19","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1176\/ajp.155.7.921","article-title":"5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation","volume":"155","author":"Kapur","year":"1998","journal-title":"Am. J. Psychiat."},{"key":"10.1016\/S0306-4530(02)00130-0_BIB20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/BF02245602","article-title":"Mechanisms of actions of atypical antipsychotic drugs: a critical analysis","volume":"124","author":"Kinon","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/S0306-4530(02)00130-0_BIB21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00004714-199902000-00011","article-title":"Prolactin levels and adverse events in patients treated with risperidone","volume":"19","author":"Kleinberg","year":"1999","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/S0306-4530(02)00130-0_BIB22","series-title":"The Antipsychotics and Sexual Functioning Questionnaire (ASFQ)","author":"Knegtering","year":"2001"},{"issue":"1\u20133","key":"10.1016\/S0306-4530(02)00130-0_BIB23","first-page":"355","article-title":"Sexual dysfunctions and prolactin levels in patients using classical antipsychotics, risperidone or olanzapine","volume":"36","author":"Knegtering","year":"1999","journal-title":"Schizophr. Res."},{"key":"10.1016\/S0306-4530(02)00130-0_BIB24","unstructured":"Knegtering, H., Boks, M.P.M., Blijd, C., van den Bosch, R.J., Wiersma, D., 2002. Sexual dysfunctions in patients using risperidone or olanzapine, a randomized trial. Submitted for publication."},{"key":"10.1016\/S0306-4530(02)00130-0_BIB25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1017\/S092427080003578X","article-title":"Serum prolactin levels and sexual dysfunction in antipsychotic medication, such as risperidon: a review","volume":"12","author":"Knegtering","year":"2000","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/S0306-4530(02)00130-0_BIB26","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1176\/ajp.133.1.82","article-title":"Thioridazine and sexual dysfunction","volume":"133","author":"Kotin","year":"1976","journal-title":"Am. J. Psychiat."},{"issue":"Suppl.","key":"10.1016\/S0306-4530(02)00130-0_BIB27","first-page":"76s","article-title":"The UKU side effect rating scale for psychotropic drugs and a cross sectional study of side effects in psychotic patients","volume":"334","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/S0306-4530(02)00130-0_BIB28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02791072.1992.10471616","article-title":"Psychoactive drugs and human sexual behavior: the role of serotonergic activity","volume":"24","author":"Meston","year":"1992","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/S0306-4530(02)00130-0_BIB29","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/archpsyc.57.11.1012","article-title":"The neurobiology of sexual function","volume":"57","author":"Meston","year":"2000","journal-title":"Arch. Gen. Psychiat."},{"key":"10.1016\/S0306-4530(02)00130-0_BIB30","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archpsyc.1974.01760160102021","article-title":"Serum prolactin levels in unmedicated schizophrenic patients","volume":"31","author":"Melzer","year":"1974","journal-title":"Arch. Gen. Psychiat."},{"key":"10.1016\/S0306-4530(02)00130-0_BIB31","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/BF01541435","article-title":"Sexual behavior of the male schizophrenic: the impact of illness and medication","volume":"41","author":"Nestoros","year":"1981","journal-title":"Arch. Sex. Behav."},{"key":"10.1016\/S0306-4530(02)00130-0_BIB32","first-page":"454","article-title":"The importance of hyperprolactinaemia in impotence","volume":"111","author":"Netto","year":"1993","journal-title":"Rev. Paul Med."},{"key":"10.1016\/S0306-4530(02)00130-0_BIB33","first-page":"315","article-title":"Priapism associated with psychotropic drugs","volume":"55","author":"Patel","year":"1996","journal-title":"Br. J. Hosp. Med."},{"issue":"Suppl.","key":"10.1016\/S0306-4530(02)00130-0_BIB34","doi-asserted-by":"crossref","first-page":"23s","DOI":"10.1016\/S0924-9338(97)89490-4","article-title":"Sexual dysfunction and antipsychotics","volume":"13","author":"Peuskens","year":"1998","journal-title":"Eur. Psychiat."},{"key":"10.1016\/S0306-4530(02)00130-0_BIB35","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2190\/P60R-PLED-TL09-TUEN","article-title":"Genitourinary and sexual adverse effects of psychotropic medication","volume":"22","author":"Pollack","year":"1992","journal-title":"Int. J. Psychol. Med."},{"key":"10.1016\/S0306-4530(02)00130-0_BIB36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0006-3223(94)91147-9","article-title":"Circadian rhythm of tryptophan, serotonin, melatonin and pituitary hormones in schizophrenia","volume":"35","author":"Rao","year":"1994","journal-title":"Biol. Psychiat."},{"key":"10.1016\/S0306-4530(02)00130-0_BIB37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000118610","article-title":"Effects of treatment with various doses of haloperidol on the pituitary-gonadal axis in male schizophrenic patients","volume":"22","author":"Rinieris","year":"1989","journal-title":"Neuropsychobiology"},{"key":"10.1016\/S0306-4530(02)00130-0_BIB38","first-page":"193","article-title":"Adverse events associated with neuroleptic drugs: focus on neuroendocrine reactions","volume":"21","author":"Santoni","year":"1995","journal-title":"Acta Therap."},{"key":"10.1016\/S0306-4530(02)00130-0_BIB39","first-page":"861","article-title":"Hyperprolactinemia and sexual disorders in men","volume":"17","author":"Schwartz","year":"1982","journal-title":"Biol. Psychiat."},{"key":"10.1016\/S0306-4530(02)00130-0_BIB40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/archpsyc.1989.01810030081011","article-title":"Effects of psychotrophic drugs on human erection and ejaculation","volume":"46","author":"Segraves","year":"1989","journal-title":"Arch. Gen. Psychiat."},{"key":"10.1016\/S0306-4530(02)00130-0_BIB41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0447.1998.tb10046.x","article-title":"Prolactogenic effects of risperidone in male patients\u2014a preliminary study","volume":"98","author":"Shiwach","year":"1998","journal-title":"Acta Psychiatr. Scand."},{"issue":"1 (special issue)","key":"10.1016\/S0306-4530(02)00130-0_BIB42","first-page":"218","article-title":"Antipsychotics and Hypogonadism in Patients with Schizophrenia","volume":"41","author":"Smith","year":"2000","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/S0306-4530(02)00130-0_BIB43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2165\/00002018-200022030-00004","article-title":"Tolerability of atypical antipsychotics","volume":"22","author":"Stanniland","year":"2000","journal-title":"Drug Safety"},{"key":"10.1016\/S0306-4530(02)00130-0_BIB44","first-page":"49","article-title":"Psychopharmak bedingte Veranderungen der Sexualitat (Haufigkeit und Stellwert in der psychiatrischen Praxis)","volume":"11","author":"Strauss","year":"1984","journal-title":"Psychiatr. Prax."},{"key":"10.1016\/S0306-4530(02)00130-0_BIB45","first-page":"1238","article-title":"Sexual side effects of antipsychotic medication: evaluation and interventions","volume":"41","author":"Sullivan","year":"1990","journal-title":"Hosp. Community Psychiat."},{"key":"10.1016\/S0306-4530(02)00130-0_BIB46","series-title":"Williams Textbook of Endocrinology","first-page":"288","article-title":"The anterior pituitary","author":"Thorner","year":"1998"},{"key":"10.1016\/S0306-4530(02)00130-0_BIB47","first-page":"355","article-title":"Effects of amantadine on sexual dysfunction in neuroleptic-treated male schizophrenic patients","volume":"21","author":"Valevski","year":"1998","journal-title":"Clin. Neuropharmacol."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453002001300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453002001300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:23:59Z","timestamp":1759681439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453002001300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":47,"alternative-id":["S0306453002001300"],"URL":"https:\/\/doi.org\/10.1016\/s0306-4530(02)00130-0","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2003,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning?","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0306-4530(02)00130-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Science Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}